SA50 Comparative Efficacy of Bimekizumab in Biologic/Targeted Synthetic DMARD-Naïve Patients with Axial Spondyloarthritis: Results from a Systematic Literature Review and Network Meta-Analysis
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2266
https://www.valueinhealthjournal.com/article/S1098-3015(23)02366-5/fulltext
Title :
SA50 Comparative Efficacy of Bimekizumab in Biologic/Targeted Synthetic DMARD-Naïve Patients with Axial Spondyloarthritis: Results from a Systematic Literature Review and Network Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02366-5&doi=10.1016/j.jval.2023.03.2266
First page :
Section Title :
Open access? :
No
Section Order :
11587